Lung Allocation in the United States

Lung and Heart–Lung Transplantation

Volumn , Issue , 2006, Pages 285-300

  Egan, Thomas M ^a   Edwards, Leah B ^b   Coke, Matthew A ^b   Murray, Susan ^c   Shearon, Tempie H ^c   Bustam, Rami ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85142557665     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420019285-16     Document Type: Chapter

References (14)

1. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982; 306:557–564.
2. The Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986; 314:1140–1145. Lung Allocation in the United States 299
3. Department of Health and Human Services. Organ procurement and transplantation network; final rule. In: 42 CFR—Part 121: Federal Register, October 20, 1999:56649–56661.
4. Institute of Medicine, Committee on Non-Heart-Beating Transplantation II. Non-heart-beating Organ Transplantation: Practice and Protocols. Washington, DC: National Academy Press, 2000.
5. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351:24–27.
6. Liou TG, Adler FR, Cahill BC, et al. Survival effect of lung transplantation among patients with cystic fibrosis. J Am Med Assoc 2001; 286(21):2683–2689.
7. Egan T. Ethical issues in thoracic organ distribution for transplant. Am J Transplant 2003; 3(4):366–372.
8. Egan TM, Bennett LE, Garrity ER, et al. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis (abstract). J Heart Lung Transplant 2001; 20(2):242.
9. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153(4):345–352.
10. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343–349.
11. Egan TM, Bennett LE, Garrity ER, et al. Are there predictors of death at the time of listing for lung transplant? (abstract). J Heart Lung Transplant 2002; 21(1):154.
12. Egan T, McCullough K, Bustami R, et al. Predictors of death on the UNOS lung transplant waiting list (abstract). J Heart Lung Transplant 2003; 22:S147.
13. Egan T, McCullough K, Murray S, et al. Risk factors for death after lung transplant in the U.S. (abstract). J Heart Lung Transplant 2003; 22:S146–S147.
14. Egan TM. Pro/Con debate: the current time based lung allocation system should be replaced by one based on medical urgency and transplant survival: Pro. Chest 2005; 128(1):407–415.